Vir Biotechnology Inc. (VIR) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear

Vir Biotechnology Inc.

NASDAQ: VIR · Real-Time Price · USD
5.23
0.10 (1.95%)
At close: Sep 11, 2025, 3:59 PM
5.21
-0.38%
After-hours: Sep 11, 2025, 07:24 PM EDT

Vir Biotechnology Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.92 -2.19 6.51 10.29
PEG Ratio
0.12 0.01 -1.47 -0.04
PS Ratio
13.48 15.66 2.12 5.00
PB Ratio
0.87 0.85 1.62 3.80
P/FCF Ratio
-2.2 -1.69 2.10 -78.35
P/OCF Ratio
-2.24 -1.73 2.02 -114.28
OCF/S Ratio
-6.02 -9.04 1.05 -0.04
Debt / Equity Ratio
0.09 0.08 0.06 0.09
Quick Ratio
8.71 9.05 4.93 4.55
Current Ratio
8.71 9.05 4.93 4.58
Asset Turnover
0.05 0.04 0.56 0.56
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.45 -0.39 0.25 0.37
Return on Assets
-0.37 -0.32 0.18 0.27
Return on Invested Capital
-0.46 -0.38 0.25 0.16
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.99 0.97 0.91 0.94
Net Profit Margin
-7.03 -7.14 0.33 0.49
Pretax Profit Margin
-7.05 -7.29 0.48 0.51
Operating Profit Margin
-7.91 -7.94 0.53 0.25
FCF Margin
-6.11 -9.29 1.01 -0.06
EBITDA Margin
-7.24 -7.71 0.53 0.39